MDPI and ACS Style
Kutkat, O.; Kandeil, A.; Moatasim, Y.; Elshaier, Y.A.M.M.; El-Sayed, W.A.; Gaballah, S.T.; El Taweel, A.; Kamel, M.N.; El Sayes, M.; Ramadan, M.A.;
et al. In Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses. Pharmaceuticals 2022, 15, 351.
https://doi.org/10.3390/ph15030351
AMA Style
Kutkat O, Kandeil A, Moatasim Y, Elshaier YAMM, El-Sayed WA, Gaballah ST, El Taweel A, Kamel MN, El Sayes M, Ramadan MA,
et al. In Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses. Pharmaceuticals. 2022; 15(3):351.
https://doi.org/10.3390/ph15030351
Chicago/Turabian Style
Kutkat, Omnia, Ahmed Kandeil, Yassmin Moatasim, Yaseen A. M. M. Elshaier, Wael A. El-Sayed, Samir T. Gaballah, Ahmed El Taweel, Mina Nabil Kamel, Mohamed El Sayes, Mohammed A. Ramadan,
and et al. 2022. "In Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses" Pharmaceuticals 15, no. 3: 351.
https://doi.org/10.3390/ph15030351